Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
8195 | 1281 | 27.2 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
98 | 3 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//SURGERY | 75394 |
93 | 2 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//KIDNEY TRANSPLANTATION | 26351 |
8195 | 1 | BASILIXIMAB//THYMOGLOBULIN//DACLIZUMAB | 1281 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BASILIXIMAB | authKW | 853900 | 6% | 48% | 75 |
2 | THYMOGLOBULIN | authKW | 572179 | 4% | 44% | 55 |
3 | DACLIZUMAB | authKW | 367763 | 4% | 31% | 50 |
4 | ALEMTUZUMAB | authKW | 290752 | 7% | 14% | 85 |
5 | CAMPATH 1H | authKW | 249068 | 3% | 29% | 36 |
6 | RABBIT ANTITHYMOCYTE GLOBULIN | authKW | 191192 | 1% | 42% | 19 |
7 | INDUCTION THERAPY | authKW | 191162 | 4% | 15% | 52 |
8 | ANTITHYMOCYTE GLOBULIN | authKW | 162148 | 3% | 17% | 41 |
9 | TRANSPLANTATION | WoSSC | 152064 | 71% | 1% | 912 |
10 | ANTI THYMOCYTE GLOBULIN | authKW | 120394 | 2% | 21% | 24 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Transplantation | 152064 | 71% | 1% | 912 |
2 | Surgery | 18940 | 64% | 0% | 821 |
3 | Immunology | 16941 | 55% | 0% | 701 |
4 | Urology & Nephrology | 855 | 8% | 0% | 105 |
5 | Respiratory System | 112 | 3% | 0% | 39 |
6 | Cardiac & Cardiovascular System | 72 | 4% | 0% | 55 |
7 | Hematology | 41 | 3% | 0% | 33 |
8 | Pediatrics | 39 | 3% | 0% | 38 |
9 | Medicine, General & Internal | 20 | 4% | 0% | 47 |
10 | Pharmacology & Pharmacy | 11 | 5% | 0% | 59 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | KLIN ALLGEMEIN VISZERAL TRANSPLANTAT MED | 47671 | 0% | 100% | 2 |
2 | TRANSPLANTAT | 36024 | 7% | 2% | 96 |
3 | PHARMACOECON TRANSPLANT | 31779 | 0% | 67% | 2 |
4 | SERV NEPHROL HTA DIALYSE TRANSPLANTAT | 31779 | 0% | 67% | 2 |
5 | A UCL NEPHROL | 23835 | 0% | 100% | 1 |
6 | ABT MED STAT INFORMAT GESUNDHEITSOKONOMIE | 23835 | 0% | 100% | 1 |
7 | AFFILIATED UROL NEPHROL HOSP | 23835 | 0% | 100% | 1 |
8 | AZIENDA OSPED P A GIOVANNI 23OSPED RIUNITI | 23835 | 0% | 100% | 1 |
9 | BARNES JEWISH HOSPRENAL | 23835 | 0% | 100% | 1 |
10 | CARDIOL MED VASC TECNOL MONTERREY | 23835 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TRANSPLANTATION PROCEEDINGS | 94942 | 31% | 1% | 398 |
2 | TRANSPLANTATION | 51919 | 16% | 1% | 200 |
3 | CLINICAL TRANSPLANTATION | 17307 | 4% | 1% | 52 |
4 | TRANSPLANT INTERNATIONAL | 17092 | 4% | 2% | 47 |
5 | TRANSPLANT IMMUNOLOGY | 14133 | 2% | 2% | 26 |
6 | AMERICAN JOURNAL OF TRANSPLANTATION | 11511 | 4% | 1% | 48 |
7 | PEDIATRIC TRANSPLANTATION | 7544 | 2% | 1% | 27 |
8 | ANNALS OF TRANSPLANTATION | 5577 | 1% | 2% | 13 |
9 | JOURNAL OF HEART AND LUNG TRANSPLANTATION | 5410 | 3% | 1% | 33 |
10 | JOURNAL OF HEART TRANSPLANTATION | 3301 | 0% | 2% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BASILIXIMAB | 853900 | 6% | 48% | 75 | Search BASILIXIMAB | Search BASILIXIMAB |
2 | THYMOGLOBULIN | 572179 | 4% | 44% | 55 | Search THYMOGLOBULIN | Search THYMOGLOBULIN |
3 | DACLIZUMAB | 367763 | 4% | 31% | 50 | Search DACLIZUMAB | Search DACLIZUMAB |
4 | ALEMTUZUMAB | 290752 | 7% | 14% | 85 | Search ALEMTUZUMAB | Search ALEMTUZUMAB |
5 | CAMPATH 1H | 249068 | 3% | 29% | 36 | Search CAMPATH+1H | Search CAMPATH+1H |
6 | RABBIT ANTITHYMOCYTE GLOBULIN | 191192 | 1% | 42% | 19 | Search RABBIT+ANTITHYMOCYTE+GLOBULIN | Search RABBIT+ANTITHYMOCYTE+GLOBULIN |
7 | INDUCTION THERAPY | 191162 | 4% | 15% | 52 | Search INDUCTION+THERAPY | Search INDUCTION+THERAPY |
8 | ANTITHYMOCYTE GLOBULIN | 162148 | 3% | 17% | 41 | Search ANTITHYMOCYTE+GLOBULIN | Search ANTITHYMOCYTE+GLOBULIN |
9 | ANTI THYMOCYTE GLOBULIN | 120394 | 2% | 21% | 24 | Search ANTI+THYMOCYTE+GLOBULIN | Search ANTI+THYMOCYTE+GLOBULIN |
10 | ANTI IL 2 RECEPTOR | 99313 | 0% | 83% | 5 | Search ANTI+IL+2+RECEPTOR | Search ANTI+IL+2+RECEPTOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HARDINGER, KL , BRENNAN, DC , KLEIN, CL , (2013) SELECTION OF INDUCTION THERAPY IN KIDNEY TRANSPLANTATION.TRANSPLANT INTERNATIONAL. VOL. 26. ISSUE 7. P. 662 -672 | 68 | 81% | 11 |
2 | MCKEAGE, K , MCCORMACK, PL , (2010) BASIFIXIMAB A REVIEW OF ITS USE AS INDUCTION THERAPY IN RENAL TRANSPLANTATION.BIODRUGS. VOL. 24. ISSUE 1. P. 55-76 | 68 | 72% | 19 |
3 | WEBSTER, AC , RUSTER, LP , MCGEE, R , MATHESON, SL , HIGGINS, GY , WILLIS, NS , CHAPMAN, JR , CRAIG, JC , (2010) INTERLEUKIN 2 RECEPTOR ANTAGONISTS FOR KIDNEY TRANSPLANT RECIPIENTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 1. P. - | 80 | 55% | 39 |
4 | MOURAD, G , MORELON, E , NOEL, C , GLOTZ, D , LEBRANCHU, Y , (2012) THE ROLE OF THYMOGLOBULIN INDUCTION IN KIDNEY TRANSPLANTATION: AN UPDATE.CLINICAL TRANSPLANTATION. VOL. 26. ISSUE 5. P. E450-E464 | 68 | 65% | 14 |
5 | BOWMAN, LJ , EDWARDS, A , BRENNAN, DC , (2014) THE ROLE OF RABBIT ANTITHYMOCYTE GLOBULIN IN RENAL TRANSPLANTATION.EXPERT OPINION ON ORPHAN DRUGS. VOL. 2. ISSUE 9. P. 971 -987 | 60 | 73% | 0 |
6 | MOHTY, M , BACIGALUPO, A , SALIBA, F , ZUCKERMANN, A , MORELON, E , LEBRANCHU, Y , (2014) NEW DIRECTIONS FOR RABBIT ANTITHYMOCYTE GLOBULIN (THYMOGLOBULIN (R)) IN SOLID ORGAN TRANSPLANTS, STEM CELL TRANSPLANTS AND AUTOIMMUNITY.DRUGS. VOL. 74. ISSUE 14. P. 1605 -1634 | 98 | 40% | 9 |
7 | THIYAGARAJAN, UM , PONNUSWAMY, A , BAGUL, A , (2013) THYMOGLOBULIN AND ITS USE IN RENAL TRANSPLANTATION: A REVIEW.AMERICAN JOURNAL OF NEPHROLOGY. VOL. 37. ISSUE 6. P. 586-601 | 61 | 61% | 13 |
8 | CHAPMAN, TM , KEATING, GM , (2003) BASIFIXIMAB - A REVIEW OF ITS USE AS INDUCTION THERAPY IN RENAL TRANSPLANTATION.DRUGS. VOL. 63. ISSUE 24. P. 2803-2835 | 48 | 79% | 57 |
9 | CIANCIO, G , GAYNOR, JJ , GUERRA, G , SAGESHIMA, J , ROTH, D , CHEN, LD , KUPIN, W , MATTIAZZI, A , TUEROS, L , FLORES, S , ET AL (2017) RANDOMIZED TRIAL OF RATG/DACLIZUMAB VS. RATG/ALEMTUZUMAB AS DUAL INDUCTION THERAPY IN RENAL TRANSPLANTATION: RESULTS AT 8 YEARS OF FOLLOW-UP.TRANSPLANT IMMUNOLOGY. VOL. 40. ISSUE . P. 42 -50 | 40 | 71% | 0 |
10 | CIANCIO, G , GAYNOR, JJ , GUERRA, G , SAGESHIMA, J , CHEN, L , MATTIAZZI, A , ROTH, D , KUPIN, W , TUEROS, L , FLORES, S , ET AL (2014) RANDOMIZED TRIAL OF THREE INDUCTION ANTIBODIES IN KIDNEY TRANSPLANTATION: LONG-TERM RESULTS.TRANSPLANTATION. VOL. 97. ISSUE 11. P. 1128-1138 | 39 | 70% | 10 |
Classes with closest relation at Level 1 |